Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targeted therapy. The use of EGFR inhibitors in patient t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: PAPADOPOULOU, EIRINI, TSOULOS, NIKOLAOS, TSIRIGOTI, ANGELIKI, APESSOS, ANGELA, AGIANNITOPOULOS, KONSTANTINOS, METAXA-MARIATOU, VASILIKI, ZAROGOULIDIS, KONSTANTINOS, ZAROGOULIDIS, PAVLOS, KASARAKIS, DIMITRIOS, KAKOLYRIS, STYLIANOS, DAHABREH, JUBRAIL, VLASTOS, FOTIS, ZOUBLIOS, CHARALAMPOS, RAPTI, AGGELIKI, PAPAGEORGIOU, NIKI GEORGATOU, VELDEKIS, DIMITRIOS, GAGA, MINA, ARAVANTINOS, GERASIMOS, KARAVASILIS, VASILEIOS, KARAGIANNIDIS, NAPOLEON, NASIOULAS, GEORGE
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2015
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4579824/
https://ncbi.nlm.nih.gov/pubmed/26622815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3600
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares